Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Alexandra Knatchbull joins CRA's Risk, Investigations & Analytics Practice in Europe
CRA is proud to welcome Alexandra Knatchbull as Vice President to our Risk, Investigations & Analytics Practice in London. Alexandra will lead the firm’s...